Literature DB >> 22699181

Reversal of warfarin anticoagulation with prothrombin complex concentrate before thrombolysis for acute stroke.

Shirin Jalini1, Albert Y Jin, Sean W Taylor.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22699181     DOI: 10.1159/000339014

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN: 1015-9770            Impact factor:   2.762


× No keyword cloud information.
  6 in total

Review 1.  [Direct oral anticoagulants and acute stroke : Insights into translational research studies].

Authors:  C Foerch; J H Schäfer; W Pfeilschifter; F Bohmann
Journal:  Nervenarzt       Date:  2017-06       Impact factor: 1.214

2.  European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke.

Authors:  Eivind Berge; William Whiteley; Heinrich Audebert; Gian Marco De Marchis; Ana Catarina Fonseca; Chiara Padiglioni; Natalia Pérez de la Ossa; Daniel Strbian; Georgios Tsivgoulis; Guillaume Turc
Journal:  Eur Stroke J       Date:  2021-02-19

3.  Reversal of Vitamin K Antagonist Therapy by Prothrombin Complex Concentrate before Thrombolysis for Acute Stroke.

Authors:  Nicolas Chausson; Manvel Aghasaryan; Djibril Soumah; Tony Altarcha; Didier Smadja
Journal:  Cerebrovasc Dis Extra       Date:  2013-06-13

4.  Prothrombin complex concentrate for rapid reversal of warfarin anticoagulation to allow neuraxial blockade.

Authors:  Conor Skerritt; Stephen Mannion
Journal:  Case Rep Anesthesiol       Date:  2014-03-04

5.  Consensus Guides on Stroke Thrombolysis for Anticoagulated Patients from Japan: Application to Other Populations.

Authors:  Kazunori Toyoda; Hiroshi Yamagami; Masatoshi Koga
Journal:  J Stroke       Date:  2018-09-30       Impact factor: 6.967

6.  Is intravenous thrombolysis safe for acute ischemic stroke patients taking warfarin with INR 1.9?: A case report.

Authors:  Zhaokun Li; Jing Su; Shanshan Zhang; Hongcai Du; Yufeng Tang; Jingfeng Duan; Zhonglun Chen
Journal:  Medicine (Baltimore)       Date:  2020-03       Impact factor: 1.889

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.